
Sanofi has refused both requests from the Government of the Philippines to refund used doses of its Dengvaxia vaccine as …

The majority of fixed dose combination (FDC) antibiotics that are made and sold in India are still unapproved, despite promises …

Bad news for breast cancer patients in the UK as the National Institute for Health and Care Excellence announces it …

Allergan has announced that the FDA has awarded approval to its fixed-dose combination antibacterial Avycaaz (ceftazidme and avibactam) for the …

On the day that a new campaign for greater awareness of stroke symptoms has been released, new figures show that …

NICE has given the nod to Roche’s Perjeta for routine first-line use, alongside Herceptin and chemotherapy, in patients with HER2-positive …

Texas-based clinical-stage company Bellicum Pharmaceuticals has taken a massive stock hit after the FDA put a hold on its trials …

To say January was a bleak month for Alzheimer’s research would be something of an understatement: Pfizer ducked out of …

Things don’t always go quite according to plan in the biotech world – something both Seattle Genetics and Cascadian Therapeutics …

Dr Brenda Fitzgerald, the Director of the Centers for Disease Control and Prevention, the United States’ leading national public health …

Ipsen has announced that Sotirios G. Stergiopoulos will become its newest Chief Medical Officer, performing the role alongside his current …

UK charity Breast Cancer Care (BCC) is set to expand the development of its end-of-treatment support app after receiving a …

NHS Digital, the Department of Health and the Home Office have been strongly criticised for entering a memorandum of understanding …

Pfizer has entered into a partnership with the Indian Council of Medical Research (ICMR) in an effort to fight antimicrobial …

Amazon’s move into the healthcare sector has been widely mooted over the last 12 months and it officially announced that …